Cargando…
Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
We aim to determine the clinical usefulness of pre-operative serum vascular endothelial growth factor (VEGF) as a predictor of outcome in patients undergoing curative resection for colorectal cancer. Serum VEGF was assayed by quantitative ELISA in 81 patients prior to curative resection for node-neg...
Autores principales: | Chin, K-F, Greenman, J, Gardiner, E, Kumar, H, Topping, K, Monson, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363412/ https://www.ncbi.nlm.nih.gov/pubmed/11076648 http://dx.doi.org/10.1054/bjoc.2000.1508 |
Ejemplares similares
-
Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
por: Choi, J-H, et al.
Publicado: (2001) -
Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy
por: Kim, Yeon-Ji, et al.
Publicado: (2019) -
Evaluation of a follow-up programme after curative resection for colorectal cancer
por: Howell, J D, et al.
Publicado: (1999) -
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?
por: Heer, K., et al.
Publicado: (1998) -
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)